Jump to ContentJump to Main Navigation
Estrogens and MemoryBasic Research and Clinical Implications$
Users without a subscription are not able to see the full content.

Karyn M. Frick

Print publication date: 2020

Print ISBN-13: 9780190645908

Published to Oxford Scholarship Online: February 2020

DOI: 10.1093/oso/9780190645908.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2020. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 28 March 2020

Estrogen Treatment in Alzheimer’s Disease

Estrogen Treatment in Alzheimer’s Disease

Translational Implications of Estrogenic Regulation of Memory for Aging and Disease

Chapter:
(p.347) 19 Estrogen Treatment in Alzheimer’s Disease
Source:
Estrogens and Memory
Author(s):

Kelly N. Morgan

Carey E. Gleason

Publisher:
Oxford University Press
DOI:10.1093/oso/9780190645908.003.0020

An effort to mitigate the cumbersome physiological, cognitive, and psychological changes that naturally occur during the menopausal transition has been ongoing for decades. Discrepant findings of symptom presentation and mediation across translational models and among human studies have perplexed researchers for years. Specifically, as an understanding of the role of estrogenic signaling in processes underlying cognition and emotion regulation evolved, researchers speculated that exogenous hormonal therapy might modify disease/symptom onset and course. This chapter describes the variable methodological approaches that likely led to disparities in the literature around hormone therapy use, particularly as it pertains to manipulating symptom onset and course of Alzheimer’s pathology. The authors expound upon current recommendations for exogenous hormone therapy use in aging women and how researchers arrived at these conclusions. Finally, we describe remaining questions regarding hormone therapy use and its long-term impact on cognition and mood, Alzheimer’s disease biomarkers, vascular functioning, and genomic variables.

Keywords:   estrogens, cognition, hormone therapy, hormone replacement therapy, healthy-user bias, Alzheimer’s disease, Women’s Health Initiative, KEEPS, ELITE

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .